Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Five-year visual results of intravitreal bevacizumab in refractory inflammatory ocular neovascularization
Clinical Ophthalmology, Volume 6, No. 1, Year 2012
Notification
URL copied to clipboard!
Description
Purpose: To assess the 5-year visual outcome of intravitreal bevacizumab in inflammatory ocular neovascularization. Methods: Retrospective, multicenter, consecutive case series of eight patients with inflammatory ocular neovascularization refractory to standard therapy who were treated with intravitreal bevacizumab and followed for 5 years after first injection. The outcome measures included improvement of best-corrected visual acuity expressed as logarithm of minimum angle of resolution. Results: Mean best-corrected visual acuity significantly improved from 0.58 at baseline (6/23 or 20/76; standard deviation=0.32) to 0.20 at final assessment (6/10 or 20/32; standard deviation=0.25) (n=8; P=0.02), a gain of 3.8 lines (median: three injections; eight eyes; eight patients). No ocular or systemic complications from intravitreal bevacizumab were noted. Conclusion: At 5 years, intravitreal bevacizumab sustained significant visual improvement in ocular neovascularization due to a variety of inflammatory ocular diseases without major complications after a median of three injections. © 2012 Mansour et al, publisher and licensee Dove Medical Press Ltd.
Authors & Co-Authors
Mansour, Ahmad M.
Lebanon, Beirut
American University of Beirut
Lebanon, Beirut
Rafik Hariri University Hospital
Mackensen, Friederike
Germany, Heidelberg
Universität Heidelberg
Mahendradas, Padmamalini
Unknown Affiliation
Khairallah, Moncef
Tunisia, Monastir
Chu Fattouma-bourguiba
Lai, Timothy Y.Y.
Hong Kong, Hong Kong
Chinese University of Hong Kong
Bashshur, Ziad F.
Lebanon, Beirut
American University of Beirut
Statistics
Citations: 21
Authors: 6
Affiliations: 5
Identifiers
Doi:
10.2147/OPTH.S34294
ISSN:
11775467
e-ISSN:
11775483
Study Design
Cohort Study